Demant
221,00 DKK
+0,55 %
Mindre end 1K følgere
DEMANT
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Værdiansættelse
Resultatopgørelse
Resultatopgørelse
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Demant
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Omsætning | 14.946,0 | 14.469,0 | 18.388,0 | 19.705,0 | 22.443,0 | 22.419,0 | 22.971,0 |
| vækst-% | -3,2 % | 27,1 % | 7,2 % | 13,9 % | -0,1 % | 2,5 % | |
| EBITDA | 3.075,0 | 2.541,0 | 4.479,0 | 4.383,0 | 5.482,0 | 5.761,0 | 5.351,0 |
| EBIT | 2.151,0 | 1.530,0 | 3.445,0 | 3.207,0 | 4.148,0 | 4.528,0 | 3.832,0 |
| Overskud før skat | 1.911,0 | 1.336,0 | 3.243,0 | 2.927,0 | 3.394,0 | 3.716,0 | 3.101,0 |
| Netto indkomst | 1.467,0 | 1.134,0 | 2.528,0 | 2.084,0 | 1.798,0 | 2.388,0 | 1.544,0 |
| EPS | 5,98 | 4,59 | 10,28 | 9,21 | 8,04 | 10,99 | 7,31 |
| Udbytte | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Udbytte ratio | 0,0 % | 0,0 % | 0,0 % | 0,0 % | 0,0 % | 0,0 % | 0,0 % |
Lønsomhed og afkast på kapital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 20,6 % | 17,6 % | 24,4 % | 22,2 % | 24,4 % | 25,7 % | 23,3 % |
| EBIT-% | 14,4 % | 10,6 % | 18,7 % | 16,3 % | 18,5 % | 20,2 % | 16,7 % |
| ROE | 19,2 % | 13,7 % | 31,7 % | 24,3 % | 19,3 % | 24,8 % | 15,6 % |
| ROI | 6,7 % | 5,2 % | 10,2 % | 7,0 % | 5,9 % | 7,4 % | 4,0 % |